Literature DB >> 6754118

Trachoma therapy with topical tetracycline and oral erythromycin: a comparative trial.

C R Dawson, T Daghfous, I Hoshiwara, K Ramdhane, M Kamoun, C Yoneda, J Schachter.   

Abstract

Because topical antibiotic treatment has had a limited effect in previous controlled trials against trachoma, treatment with oral erythromycin was compared with topical tetracycline in 6-8-year-old children in southern Tunisia who had potentially blinding active trachoma. A total of 169 children were divided into two groups that were carefully matched for age, sex, locality, and intensity of disease. Oral erythromycin ethyl succinate in a paediatric dosage form was administered to one group and topical 1% tetracycline ointment to the other group, twice daily, six days a week for three weeks. The two treatments were equivalent in effectiveness and resulted in a substantial decrease in disease intensity and a marked reduction in chlamydial infection detected in conjunctival smears. To maintain blood levels of antibiotics known to be effective in the treatment of chlamydial infections with a dosage schedule possible in a trachoma control programme, one of the long-acting tetracyclines (doxycycline or minocycline) might be considered. Such systemic chemotherapy should be limited to selective treatment of individuals who can be adequately monitored.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6754118      PMCID: PMC2536005     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  23 in total

1.  TRIC agent infections of the eye and genital tract.

Authors:  C R Dawson; J Schachter
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

2.  Controlled treatment trials of trachoma in American Indian children.

Authors:  C R Dawson; L Hanna; E Jawetz
Journal:  Lancet       Date:  1967-11-04       Impact factor: 79.321

3.  Inclusion conjunctivitis and Reiter's syndrome in a married couple. Chlamydia infections in a series of both diseases.

Authors:  C R Dawson; J Schachter; H B Ostler; R M Gilbert; D E Smith; E P Engleman
Journal:  Arch Ophthalmol       Date:  1970-03

Review 4.  Hepatotoxicity of erythromycin.

Authors:  P Braun
Journal:  J Infect Dis       Date:  1969-03       Impact factor: 5.226

5.  Phototoxic potential of minocycline and doxycycline.

Authors:  P Frost; G D Weinstein; E C Gomez
Journal:  Arch Dermatol       Date:  1972-05

6.  Extraocular infections in children in areas with endemic trachoma.

Authors:  R Malaty; S Zaki; M E Said; D W Vastine; D W Dawson; J Schachter
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

7.  Tetracyclines and permanent teeth: the relation between dose and tooth color.

Authors:  E R Grossman; A Walchek; H Freedman
Journal:  Pediatrics       Date:  1971-03       Impact factor: 7.124

8.  Rifapicin inhibition of trachoma agent in vivo.

Authors:  Y Becker; Y Asher; N Himmel; Z Zakay-Rones; B Maythar
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

9.  Intermittent trachoma chemotherapy: a controlled trial of topical tetracycline or erythromycin.

Authors:  C R Dawson; T Daghfous; J Whitcher; M Messadi; T Hoshiwara; F Triki; F Chadgrah; O Briones; C Yoneda; J Schachter
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

10.  Studies in the epidemiology and control of seasonal conjunctivitis and trachoma in southern Morocco.

Authors:  J Reinhards; A Weber; B Nizetic; K Kupka; F Maxwell-Lyons
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

View more
  8 in total

Review 1.  Eradication of trachoma worldwide.

Authors:  D Mabey; R Bailey
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

2.  Community-based intervention programs for trachoma control.

Authors:  S West; H R Taylor
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

3.  The diagnosis and treatment of chlamydial conjunctivitis.

Authors:  H R Taylor; C P Fitch; F Murillo-Lopez; P Rapoza
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

Review 4.  Ocular Chlamydia trachomatis infection: elimination with mass drug administration.

Authors:  Meraf A Wolle; Sheila K West
Journal:  Expert Rev Anti Infect Ther       Date:  2019-02-18       Impact factor: 5.091

5.  Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial.

Authors:  Isabelle Cochereau; Pablo Goldschmidt; André Goepogui; Tayyab Afghani; Laurent Delval; Pascale Pouliquen; Tristan Bourcier; Pierre-Yves Robert
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

Review 6.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Antibiotics for trachoma.

Authors:  Jennifer R Evans; Anthony W Solomon; Rahul Kumar; Ángela Perez; Balendra P Singh; Rajat Mohan Srivastava; Emma Harding-Esch
Journal:  Cochrane Database Syst Rev       Date:  2019-09-26

8.  Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study.

Authors:  Zelalem Tilahun; Teferi Gedif Fenta
Journal:  BMC Ophthalmol       Date:  2018-08-06       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.